HCAL
XFOR icon

HURRICANE CAPITAL ADVISORS LLC’s X4 Pharmaceuticals XFOR Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,637
Closed -$214K – 722
2024
Q3 		$214K Sell
10,637
-1,491
-12% -$31.1K 0.08% 199
2024
Q2 		$211K Sell
12,128
-4,090
-25% -$134K 0.07% 188
2024
Q1 		$676K Sell
16,218
-498
-3% -$13.9K 0.19% 73
2023
Q4 		$420K Buy
+16,716
New +$406K 0.16% 91

Other funds holding XFOR

Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's XFOR Position: Q4 2024 in Review

HURRICANE CAPITAL ADVISORS LLC sold out of X4 Pharmaceuticals (XFOR) in Q4 2024, closing a stake of 10,637 shares — an estimated $214K sold.

HURRICANE CAPITAL ADVISORS LLC first reported a position in XFOR in Q4 2023 and held it in 4 quarters. The position peaked at $676K in Q1 2024. 89 funds tracked by Wall St. Rank hold XFOR as of Q4 2024.

  • HURRICANE CAPITAL ADVISORS LLC reported no remaining X4 Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • HURRICANE CAPITAL ADVISORS LLC sold 10,637 X4 Pharmaceuticals shares in Q4 2024, an estimated $214K.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in X4 Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • HURRICANE CAPITAL ADVISORS LLC's X4 Pharmaceuticals position peaked at $676K in Q1 2024.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2024.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q4 2024, filed 3 Nov 2026.